Beta Bionics (BBNX) Stock Chart & Stock Price History $17.92 +0.47 (+2.69%) As of 02:51 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Beta Bionics Stock Price Performance The Beta Bionics (BBNX) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 20.75%, reflecting recent market activity. As of the latest close, Beta Bionics traded at $17.45 with a market cap of $758.55 million and volume of 498,604 shares. Receive BBNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.10%1 Month Performance+20.75%3 Month Performance+24.19% BBNX Stock Chart for Tuesday, August, 26, 2025 BBNX Chart by TradingView Beta Bionics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$17.05$17.45+2.35%$17.83$16.92498,604 shs$758.55 million08/22/2025$16.89$17.05+0.95%$18.33$16.69892,018 shs$741.16 million08/21/2025$15.30$16.89+10.39%$17.00$15.21753,427 shs$734.21 million08/20/2025$15.88$15.30-3.65%$16.21$14.75882,127 shs$665.09 million08/19/2025$17.26$15.88-8.00%$17.20$15.86764,571 shs$690.30 million08/18/2025$17.04$17.26+1.29%$18.00$17.07709,332 shs$750.29 million08/15/2025$16.71$17.04+1.97%$17.15$16.48586,331 shs$740.73 million08/14/2025$15.10$16.71+10.66%$16.92$14.57551,430 shs$726.38 million08/13/2025$14.22$15.10+6.19%$15.24$14.131.09 million shs$656.40 million08/12/2025$14.30$14.22-0.56%$14.99$14.04540,580 shs$618.14 million Get the Latest News and Ratings for BBNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$14.74$14.30-2.99%$15.06$14.09591,637 shs$621.62 million08/08/2025$15.09$14.74-2.32%$15.67$14.48488,823 shs$640.75 million08/07/2025$15.20$15.09-0.72%$15.63$14.77448,350 shs$655.96 million08/06/2025$15.81$15.20-3.86%$16.07$14.75822,283 shs$660.74 million08/05/2025$16.42$15.81-3.71%$16.44$15.52562,948 shs$687.26 million08/04/2025$16.40$16.42+0.12%$16.67$16.13495,561 shs$713.78 million08/01/2025$16.79$16.40-2.32%$17.00$15.90514,719 shs$711.04 million07/31/2025$16.76$16.79+0.18%$17.50$16.571.13 million shs$728.01 million07/30/2025$14.66$16.76+14.32%$17.07$14.913.05 million shs$726.71 million07/29/2025$13.99$14.66+4.79%$14.82$13.75797,155 shs$635.60 million07/28/2025$14.84$13.99-5.73%$15.30$13.82546,220 shs$606.61 million07/25/2025$14.43$14.84+2.84%$15.10$14.00355,443 shs$643.46 million Related Companies Liquidia Technologies Stock Chart PROCEPT BioRobotics Stock Chart LeMaitre Vascular Stock Chart Artivion Stock Chart National Vision Stock Chart Enovis Stock Chart CONMED Stock Chart NovoCure Stock Chart SS Innovations International Stock Chart BioLife Solutions Stock Chart Receive BBNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BBNX) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access